Evaluation of Avena sativa Derived Arabinoxylans as Native Biological Response Modifiers in Broilers

Biological response modifiers.

Biological response modifiers (BRMs) of current clinical interest may be divided into two categories: immunomodulating agents and colony stimulating factors (CSFs). The first are employed to potentiate the host defences towards the tumor but results have proved disappointing in non-small cell lung cancer (NSCLC). With regard to the second, the real dose increment which may be ascribed to CSFs i...

Biological response modifiers in cancer therapy.

Biological response modifiers improve the body's ability to fight cancer by immunostimulation. Although a century has passed since the first attempt was made to stimulate the host immune system against cancer, only the past decade has witnessed the scientific use of biological response modifiers. Recent advances in tumour immunology have enabled the development of specific agents targeted again...

Assessment Report on Avena Sativa L., Herba and Avena Sativa L., Fructus

Biological response modifiers: the new immunotherapy.

Immunotherapy is divided into two overlapping categories, active and passive. The goal of active immunotherapy is the stimulation of host ant ¡tumorimmunity, either cellular or hu moral. This can be accomplished in a direct or specific fashion by using tumor vaccines to generate an immune response to tumor-associated antigens. Nonspecific antitumor immunity can be propagated by compounds such ...

Psoriatic arthritis treatment: biological response modifiers.

In recent years there has been a surge of interest in the treatment of chronic inflammatory disorders as a result of the development and application of targeted biological therapies. The elucidation of the overlapping cellular and cytokine immunopathology of such diverse conditions as rheumatoid arthritis (RA), Crohn's disease, and psoriasis points to specific targets for bioengineered proteins...